News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer
Nov 19, 2024, 02:28

The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:

“Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data – The Lancet Oncology

This prospective cohort study from Denmark investigated the potential association between aromatase inhibitor treatment (AIT) and ischemic cardiotoxicity in postmenopausal women with early Breast Cancer.”

ischaemic cardiotoxicity

Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data

Authors: Marie Luna, Giulia Corn, Maj-Britt Jensen, Tonny Petersen, Kim Dalhoff, Bent Ejlertsen, Lars Køber, Jan Wohlfahrt , Mads Melbye

The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer

More posts featuring Elisabetta Bonzano.

Bent Ejlertsen cancer Giulia Corn Jan Wohlfahrt Kim Dalhoff Lars Køber Mads Melbye Maj-Britt Jensen Marie Luna OncoDaily Oncology Tonny Petersen
Special Coverage
Blog
Apr 23, 2025, 11:43
Critical challenges in cell therapy development - Friends of Cancer Research
Blog
Apr 23, 2025, 11:31
When Circumstances Decide, Socioeconomic Status and Cancer Inequities in Europe - Youth Cancer Europe
Blog
Apr 23, 2025, 11:00
Olubukola Ayodele: The deep-rooted disparities ethnic minority groups face in breast cancer awareness, diagnosis in the UK
Science
Apr 23, 2025, 10:42
Federico Monaca: Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
Insight
Apr 23, 2025, 10:35
Vignesh Packiam: I am generally aggressive in promoting bladder sparing for NMIBC
Blog
Apr 23, 2025, 10:33
Herbert Loong: It was a real pleasure meeting so many lung cancer friends
Blog
Apr 23, 2025, 10:24
Vaccination must be central to cancer prevention strategies - European Cancer Organisation
Blog
Apr 23, 2025, 10:17
Join IARC’s new webinar series on Research for Implementation in Cancer Prevention
Drugs
Apr 23, 2025, 10:15
Binimetinib (Mektovi): What patients need to know?
Blog
Apr 23, 2025, 10:12
Matthew Kurian: From ASCENT-04 may reshape frontline therapy for mTNBC
Blog
Apr 23, 2025, 10:07
Paolo Tarantino: ADCs are rapidly moving to earlier line treatment for breast cancer
Blog
Apr 23, 2025, 10:05
Tools to help gauge your personal breast cancer risk - Susan G. Komen